Aurinia Pharmaceuticals (AUPH) Other Gross PP&E Adjustments (2019 - 2025)
Aurinia Pharmaceuticals (AUPH) has disclosed Other Gross PP&E Adjustments for 7 consecutive years, with -$73.5 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Other Gross PP&E Adjustments fell 6878.71% year-over-year to -$73.5 million, compared with a TTM value of -$73.5 million through Sep 2025, down 6878.71%, and an annual FY2024 reading of -$86.8 million, down 11432.64% over the prior year.
- Other Gross PP&E Adjustments was -$73.5 million for Q3 2025 at Aurinia Pharmaceuticals, down from $1.4 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $5.1 million in Q4 2022 and bottomed at -$112.2 million in Q2 2023.
- Average Other Gross PP&E Adjustments over 5 years is -$28.5 million, with a median of -$129000.0 recorded in 2021.
- The sharpest move saw Other Gross PP&E Adjustments skyrocketed 4057.36% in 2022, then tumbled 42431.32% in 2023.
- Year by year, Other Gross PP&E Adjustments stood at -$129000.0 in 2021, then surged by 4057.36% to $5.1 million in 2022, then plummeted by 85.0% to $766000.0 in 2023, then crashed by 11432.64% to -$86.8 million in 2024, then grew by 15.27% to -$73.5 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for AUPH at -$73.5 million in Q3 2025, $1.4 million in Q2 2025, and -$82.3 million in Q1 2025.